Ursula Quitterer
Affiliations: | 1996-2006 | Pharmacy | ETH/Uni Zurich, Zürich, Zürich, Switzerland |
Google:
"Ursula Quitterer"Mean distance: 14.87 (cluster 6) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Abd Alla J, Quitterer U. (2022) The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart. Cells. 11 |
| Perhal A, Wolf S, Jamous YF, et al. (2019) Increased Reactive Oxygen Species Generation Contributes to the Atherogenic Activity of the B2 Bradykinin Receptor. Frontiers in Medicine. 6: 32 |
| Quitterer U, AbdAlla S. (2019) Discovery of Pathologic GPCR Aggregation. Frontiers in Medicine. 6: 9 |
| Perhal A, Wolf S, Langer A, et al. (2019) The bradykinin B2 receptor enhances atherosclerotic lesion formation in hypercholesterolemic ApoE-deficient mice Naunyn-Schmiedebergs Archives of Pharmacology. 392 |
| Quitterer U, Fu X, Pohl A, et al. (2019) Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers. Cell. 176: 318-333.e19 |
| Wolf S, Abd Alla J, Quitterer U. (2018) Sensitization of the Angiotensin II AT1 Receptor Contributes to RKIP-Induced Symptoms of Heart Failure. Frontiers in Medicine. 5: 359 |
| Alla JA, Langer A, Quitterer U. (2016) Down-regulation of the chemokine (c-c motif) receptor 9 (Ccr9) contributes to the atherosclerosis-lowering activity of the angiotensin-converting enzyme inhibitor captopril Atherosclerosis. 252 |
| Abd Alla J, Graemer M, Fu X, et al. (2015) Inhibition of G-protein-coupled receptor kinase 2 prevents the dysfunctional cardiac substrate metabolism in fatty acid synthase-transgenic mice. The Journal of Biological Chemistry |
| Quitterer U, AbdAlla S. (2014) Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimer. Biochemical Pharmacology. 88: 284-90 |
| AbdAlla S, Langer A, Fu X, et al. (2013) ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease. International Journal of Molecular Sciences. 14: 16917-42 |